Table 2 Cardiovascular magnetic resonance data
|  | HFpEF (n = 18) | Healthy Control (n = 18) | p |
|---|---|---|---|
LV EDVI (mL/m2) | 87.9 ± 21.3 | 79.1 ± 18.1 | 0.189 |
LV ESVI (mL/m2) | 37.9 ± 13.9 | 29.6 ± 7.8 | 0.036 |
LV EF (%) | 57.6 ± 7.7 | 59.4 ± 14.4 | 0.646 |
LV CI (L/min/m2) | 3.27 ± 1.16 | 5.0 ± 8.21 | 0.381 |
LV mass index (g/m2) | 63.1 ± 30.7 | 43.9 ± 10.4 | 0.020 |
LV ECV (%) | 32.2 ± 3.8 | 29.9 ± 2.6 | 0.044 |
LV GLS (%) | −14.8 ± 3.3 | −19.5 ± 2.8 | < 0.001 |
LV GCS (%) | − 18.7 ± 4.2 | −22.5 ± 3.0 | 0.004 |
LV GRS (%) | 39.0 ± 14.6 | 50.9 ± 9.2 | 0.007 |
nPFR | 1.82 ± 0.50 | 2.76 ± 0.77 | < 0.001 |
LA EDVI (mL/m2) | 45.8 ± 15.7 | 33.1 ± 10.1 | 0.007 |
LA ESVI (mL/m2) | 25.7 ± 10.7 | 13.1 ± 5.4 | < 0.001 |
LA EF (%) | 44.7 ± 6.5 | 60.9 ± 6.2 | < 0.001 |
LA total strain (%) | 15.7 ± 5.1 | 18.9 ± 3.6 | 0.042 |
LA conduit strain (%) | 8.7 ± 4.0 | 10.3 ± 3.0 | 0.178 |
RV EDVI (mL/m2) | 66.6 ± 14.8 | 78.2 ± 19.6 | 0.052 |
RV ESVI (mL/m2) | 23.1 ± 9.1 | 30.1 ± 11.7 | 0.057 |
RV EF (%) | 65.5 ± 9.3 | 62.2 ± 9.4 | 0.301 |
RV GLS (%) | −20.9 ± 4.4 | −21.6 ± 4.4 | 0.643 |
RA EDVI (mL/m2) | 34.0 ± 12.7 | 28.5 ± 9.2 | 0.142 |
RA ESVI (mL/m2) | 21.0 ± 9.3 | 13.1 ± 4.5 | 0.003 |
RA EF (%) | 37.8 ± 13.6 | 52.9 ± 12.3 | 0.001 |